Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.

NCT05760456 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: DIDALA hard capsules
DRUG: Metformin

Sponsor

Centre of Clinical Pharmacology, Hanoi Medical University